Why the study?
Do humoral antibodies correlate with resistance to poliomyelitis reinfection in convalescent versus vaccinated monkeys?
Do humoral antibodies correlate with resistance to poliomyelitis reinfection in convalescent versus vaccinated monkeys?
Humoral antibodies do not have the same significance for resistance to poliomyelitis infection in vaccinated monkeys as they do in convalescent monkeys.
Answers are grounded in this paper and cite their sources.
Antibodies from vaccination may not confer nasal resistance in primate polio models; leaves open distinct convalescent mechanisms for human study.
Monkeys convalescent from a paralytic attack of poliomyelitis develop humoral antibodies slowly; in the present series their first appearance in most was at 2 months and in some not until 3 months after the attack. 2. Convalescent monkeys display resistance to reinfection with the same strain by the nasal route long before antibodies become demonstrable in their serum, in this respect differing from many vaccinated monkeys whose serum neutralizes the virus, while they remain susceptible to nasal infection. 3. When antibodies appear in the serum of resistant convalescent monkeys, they are not quantitatively greater than in the serum of vaccinated monkeys which succumb to infection. As regards resistance to infection, humoral antibodies, therefore, do not have the same significance in vaccinated as in convalescent poliomyelitis monkeys.
No takes yet. Share an insight, caveat, or question.
Sabin et al. (1936) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: